Disruptive mood dysregulation disorder

Current insights

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Disruptive mood dysregulation disorder (DMDD) was introduced as a new diagnostic entity under the category of depressive disorders in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It was included in DSM-5 primarily to address concerns about the misdiagnosis and consequent overtreatment of bipolar disorder in children and adolescents. DMDD does provide a home for a large percentage of referred children with severe persistent irritability that did not fit well into any DSM, Fourth Edition (DSM-IV) diagnostic category. However, it has been a controversial addition to the DSM-5 due to lack of published validity studies, leading to questions about its validity as a distinct disorder. In this article, the authors discuss the diagnostic criteria, assessment, epidemiology, criticism of the diagnosis, and pathophysiology, as well as treatment and future directions for DMDD. They also review the literature on severe mood dysregulation, as described by the National Institute of Mental Health, as the scientific support for DMDD is based primarily on studies of severe mood dysregulation.

Original languageEnglish (US)
Pages (from-to)2115-2124
Number of pages10
JournalNeuropsychiatric Disease and Treatment
Volume12
DOIs
StatePublished - Aug 24 2016

Fingerprint

Mood Disorders
Diagnostic and Statistical Manual of Mental Disorders
National Institute of Mental Health (U.S.)
Depressive Disorder
Diagnostic Errors
Bipolar Disorder
Epidemiology
Therapeutics

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

@article{8477c0d763d94f0eb94cb18dd39fbd5b,
title = "Disruptive mood dysregulation disorder: Current insights",
abstract = "Disruptive mood dysregulation disorder (DMDD) was introduced as a new diagnostic entity under the category of depressive disorders in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It was included in DSM-5 primarily to address concerns about the misdiagnosis and consequent overtreatment of bipolar disorder in children and adolescents. DMDD does provide a home for a large percentage of referred children with severe persistent irritability that did not fit well into any DSM, Fourth Edition (DSM-IV) diagnostic category. However, it has been a controversial addition to the DSM-5 due to lack of published validity studies, leading to questions about its validity as a distinct disorder. In this article, the authors discuss the diagnostic criteria, assessment, epidemiology, criticism of the diagnosis, and pathophysiology, as well as treatment and future directions for DMDD. They also review the literature on severe mood dysregulation, as described by the National Institute of Mental Health, as the scientific support for DMDD is based primarily on studies of severe mood dysregulation.",
author = "Raman Baweja and Susan Mayes and Usman Hameed and James Waxmonsky",
year = "2016",
month = "8",
day = "24",
doi = "10.2147/NDT.S100312",
language = "English (US)",
volume = "12",
pages = "2115--2124",
journal = "Neuropsychiatric Disease and Treatment",
issn = "1176-6328",
publisher = "Dove Medical Press Ltd.",

}

Disruptive mood dysregulation disorder : Current insights. / Baweja, Raman; Mayes, Susan; Hameed, Usman; Waxmonsky, James.

In: Neuropsychiatric Disease and Treatment, Vol. 12, 24.08.2016, p. 2115-2124.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Disruptive mood dysregulation disorder

T2 - Current insights

AU - Baweja, Raman

AU - Mayes, Susan

AU - Hameed, Usman

AU - Waxmonsky, James

PY - 2016/8/24

Y1 - 2016/8/24

N2 - Disruptive mood dysregulation disorder (DMDD) was introduced as a new diagnostic entity under the category of depressive disorders in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It was included in DSM-5 primarily to address concerns about the misdiagnosis and consequent overtreatment of bipolar disorder in children and adolescents. DMDD does provide a home for a large percentage of referred children with severe persistent irritability that did not fit well into any DSM, Fourth Edition (DSM-IV) diagnostic category. However, it has been a controversial addition to the DSM-5 due to lack of published validity studies, leading to questions about its validity as a distinct disorder. In this article, the authors discuss the diagnostic criteria, assessment, epidemiology, criticism of the diagnosis, and pathophysiology, as well as treatment and future directions for DMDD. They also review the literature on severe mood dysregulation, as described by the National Institute of Mental Health, as the scientific support for DMDD is based primarily on studies of severe mood dysregulation.

AB - Disruptive mood dysregulation disorder (DMDD) was introduced as a new diagnostic entity under the category of depressive disorders in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It was included in DSM-5 primarily to address concerns about the misdiagnosis and consequent overtreatment of bipolar disorder in children and adolescents. DMDD does provide a home for a large percentage of referred children with severe persistent irritability that did not fit well into any DSM, Fourth Edition (DSM-IV) diagnostic category. However, it has been a controversial addition to the DSM-5 due to lack of published validity studies, leading to questions about its validity as a distinct disorder. In this article, the authors discuss the diagnostic criteria, assessment, epidemiology, criticism of the diagnosis, and pathophysiology, as well as treatment and future directions for DMDD. They also review the literature on severe mood dysregulation, as described by the National Institute of Mental Health, as the scientific support for DMDD is based primarily on studies of severe mood dysregulation.

UR - http://www.scopus.com/inward/record.url?scp=84985918770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84985918770&partnerID=8YFLogxK

U2 - 10.2147/NDT.S100312

DO - 10.2147/NDT.S100312

M3 - Review article

VL - 12

SP - 2115

EP - 2124

JO - Neuropsychiatric Disease and Treatment

JF - Neuropsychiatric Disease and Treatment

SN - 1176-6328

ER -